Common use of Ownership of Study Data Clause in Contracts

Ownership of Study Data. BMS shall own the Study Data to the extent that it relates exclusively to the BMS Compound (“BMS Study Data”), and Exelixis shall own the Study Data to the extent that it relates exclusively to the Exelixis Compound (“Exelixis Study Data”). The Parties shall jointly own (BMS to own 50% and Exelixis to own 50%) any Study Data that does not relate exclusively to the Exelixis Compound or the BMS Compound (“Combined Therapy Study Data”). Each Party shall, and does hereby, assign, and shall cause its Affiliates to so assign, to the other Party, without additional compensation, such right, title and interest in and to any Study Data as is necessary to fully effect the foregoing, and agrees to execute all instruments as may be reasonably necessary to effect same.

Ownership of Study Data. BMS shall own the Study Data to the extent that it relates exclusively pertaining solely to the BMS Compound Study Drug (“BMS Study Data”), and Exelixis Recipient shall own the Study Data pertaining solely to the extent that it relates exclusively to the Exelixis Compound Recipient FDC (“Exelixis Recipient Study Data”). The Subject to the restrictions on use and disclosure as set forth in this Agreement, both Parties shall jointly own (BMS to own 50% and Exelixis to own 50%) any Study Data that does is not relate exclusively to BMS Study Data or Recipient Study Data (such jointly owned Study Data being the Exelixis Compound or the BMS Compound (“Combined Therapy Study Data”). Each Party shall, and does hereby, assign, and shall cause its Affiliates to so assign, to the other Party, without additional compensation, such right, title and interest in and to any Study Data as is necessary to fully effect the foregoing, and agrees to execute all instruments as may be reasonably necessary to effect same.

Ownership of Study Data. BMS shall own the Study Data to the extent that it relates exclusively solely to the BMS Compound (“BMS Study Data”), and Exelixis the Company shall own the Study Data to the extent that it relates exclusively solely to the Exelixis Compound Company Compounds (“Exelixis Company Study Data”). The Subject to the restrictions on use and disclosure as set forth in this Agreement, both Parties shall jointly own (BMS to own 50% and Exelixis to own 50%) any Study Data that does is not relate exclusively to BMS Study Data or Company Study Data (such jointly owned Study Data being the Exelixis Compound or the BMS Compound (“Combined Therapy Study Data”). Each Party shall, and does hereby, assign, and shall cause its Affiliates to so assign, to the other Party, without additional compensation, such right, title and interest in and to any Study Data as is necessary to fully effect the foregoing, and agrees to execute all instruments as may be reasonably necessary to effect same.